We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

180 hedge funds and large institutions have $2.77B invested in SpringWorks Therapeutics in 2023 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 78 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more call options, than puts

Call options by funds: $29.4M | Put options by funds: $6.84M

165% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 20

129% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 34

125% more funds holding in top 10

Funds holding in top 10: 4 → 9 (+5)

75% more capital invested

Capital invested by funds: $1.58B → $2.77B (+$1.19B)

22% more funds holding

Funds holding: 147 → 180 (+33)

4.05% less ownership

Funds ownership: 109.42% → 105.37% (-4%)

Holders
180
Holders Change
+33
Holders Change %
+22.45%
% of All Funds
2.62%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.13%
New
53
Increased
78
Reduced
34
Closed
20
Calls
$29.4M
Puts
$6.84M
Net Calls
+$22.6M
Net Calls Change
+$22.8M

Top Buyers

Rank Fund Capital Flow
1
MC
Maverick Capital
Texas
+$58.3M
2
Marshall Wace
Marshall Wace
United Kingdom
+$45.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$42.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$37.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$31.9M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$80M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$71.2M
3
BBA
Baker Bros. Advisors
New York
-$69.4M
4
O
OrbiMed
New York
-$19.6M
5
DCM
Driehaus Capital Management
Illinois
-$10.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
176
PNC Financial Services Group
Pennsylvania
$1.02K +$470 +18 +180%
BTI
177
Blue Trust Inc
Georgia
$1K +$1.33K +51 New
FCA
178
FinTrust Capital Advisors
South Carolina
$730 – – –
BIA
179
Bell Investment Advisors
California
$657 – – –
EC
180
EcoR1 Capital
California
– -$80M -3,460,208 Closed
BCLSI
181
Bain Capital Life Sciences Investors
Massachusetts
– -$71.2M -3,081,307 Closed
BBA
182
Baker Bros. Advisors
New York
– -$69.4M -2,999,846 Closed
IC
183
Ikarian Capital
Texas
– -$4.12M -178,360 Closed
ITP
184
Iron Triangle Partners
Connecticut
– -$3.47M -150,211 Closed
Walleye Capital
185
Walleye Capital
New York
– -$3.34M -144,307 Closed
TC
186
TwinBeech Capital
New York
– -$2.83M -122,429 Closed
Balyasny Asset Management
187
Balyasny Asset Management
Illinois
– -$1.09M -47,218 Closed
BFM
188
Boothbay Fund Management
New York
– -$889K -38,447 Closed
Squarepoint
189
Squarepoint
New York
– -$781K -33,768 Closed
FSA
190
Financial Security Advisor
Virginia
– -$734K -31,758 Closed
EGM
191
Engineers Gate Manager
New York
– -$651K -28,178 Closed
ECM
192
ExodusPoint Capital Management
New York
– -$625K -27,022 Closed
Two Sigma Advisers
193
Two Sigma Advisers
New York
– -$287K -12,400 Closed
Walleye Trading
194
Walleye Trading
New York
– -$191K -8,242 Closed
QCG
195
Quadrant Capital Group
Ohio
– -$1.2K -52 Closed
PPC
196
Park Place Capital
Alabama
– -$555 -24 Closed
GWS
197
Glassman Wealth Services
Virginia
– -$277 -12 Closed
HI
198
Harbour Investments
Wisconsin
– -$231 -10 Closed
LFG
199
Larson Financial Group
Missouri
– -$208 -9 Closed
4 5 6 7
8

SWTX Hedge Fund Activity: Q4 2023 in Review

180 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2023, worth a combined $2.77B — up 75% from $1.58B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new SWTX positions and 20 closed out — a net gain of 33 holders — while 78 added to existing stakes and 34 trimmed.

The largest buyer was Maverick Capital, adding an estimated $58.3M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $80M sold.

  • 180 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2023, up from 147 in Q3 2023.
  • Funds reported $2.77B of SpringWorks Therapeutics stock for Q4 2023, up 75% quarter-over-quarter.
  • 53 funds opened new SpringWorks Therapeutics positions in Q4 2023 and 20 closed out, a net change of +33 holders.
  • The largest SpringWorks Therapeutics buyer in Q4 2023 was Maverick Capital, an estimated $58.3M added.
  • The largest SpringWorks Therapeutics seller in Q4 2023 was EcoR1 Capital, an estimated $80M sold.

Based on aggregated 13F filings for Q4 2023.